Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,027 public trials 2,025 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT04665765

Conditions: Diffuse Large B-Cell Lymphoma Unclassifiable, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: City of Hope Medical Center Duarte, California, United States

Emory University Atlanta, Georgia, United States

View Trial Details

Active, Not Recruiting

Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax

NCT04501939

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: UCSD Koman Family Outpatient Pavilion San Diego, California, United States

View Trial Details

Active, Not Recruiting

Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation

NCT01810588

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Malignancies, +12 more
Locations: University of Chicago Medical Center Chicago, Illinois, United States

Weill Cornell Medical College New York, United States

View Trial Details

Active, Not Recruiting

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

NCT02475681

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Research Site Goodyear, Arizona, United States

Research Site Phoenix, Arizona, United States

Research Site Anaheim, California, United States

Research Site Los Angeles, California, United States

View all 155 locations

View Trial Details

Active, Not Recruiting

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia

NCT02028455

Conditions: CD19+ Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital Oakland Oakland, California, United States

Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

NCT04464200

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
Locations: Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Active, Not Recruiting

Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.

NCT05788081

Conditions: Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV, +10 more
Locations: Grampians Health Ballarat, Victoria, Australia

Eastern Health Box Hill, Victoria, Australia

University Hospital Geelong, Barwon Health Geelong, Victoria, Australia

Austin Health Heidelberg, Victoria, Australia

View Trial Details

Active, Not Recruiting

Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment

NCT03505762

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Active, Not Recruiting

Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae

NCT04541056

Conditions: Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia, Childhood Non-Hodgkin Lymphoma, +11 more
Locations: Oslo University Hospital - Rikshospitalet Oslo, Norway

St. Olavs Hospital Trondheim, Norway

Department of Psychology, Norwegian University of Science and Technology (NTNU) Trondheim, Norway

View Trial Details

Active, Not Recruiting

Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation

NCT06328699

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions